Nantahala Capital Management, LLC Eloxx Pharmaceuticals, Inc. Transaction History

Nantahala Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.58 $185,944 - $449,364	-774,767 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.4 - $0.72 $47,956 - $86,322	-119,892 Reduced 13.4%	774,767 $434,000
Q4 2021 Feb 14, 2022	SELL	$0.62 - $1.61 $195,100 - $506,633	-314,679 Reduced 26.02%	894,659 $632,000
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.0 $1.29 Million - $2.11 Million	-1,056,949 Reduced 46.64%	1,209,338 $1.97 Million
Q2 2021 Aug 16, 2021	BUY	$1.35 - $3.36 $3.06 Million - $7.61 Million	2,266,287 New	2,266,287 $4.51 Million

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.